RIANA RIZZO: Open Payments
NPI 1265185110 · MOORESTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$197 in 12 payments from 9 companies in 2025. Trend: 2023 $131 · 2024 $120 · 2025 $197
Food & beverage: $197
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Exact Sciences Corporation | 1 | $20 |
| SANOFI-AVENTIS U.S. LLC | 1 | $19 |
| Novo Nordisk Inc | 1 | $15 |
| Amgen Inc. | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
Products named: SHINGRIX, JARDIANCE, The Cologuard Plus Collection Kit, TZIELD, Rybelsus, EVENITY, CAPVAXIVE, VRAYLAR.
Industry payments across NJ — which companies pay providers there.
